Webinar 4 - News & Views in anxiety disorders
November 5, 2020 (16:00, UTC+2)
David Baldwin (United Kingdom)
Registration Fees per Webinar
Join the conversation online on Facebook, LinkedIn, or Twitter using our official hashtag: #CINPOnline
Katharina Domschke, Germany (Speaker)
Prof. Katharina Domschke, MA, MD, PhD, is Full Professor and Chair of the Dept. of Psychiatry and Psychotherapy, University of Freiburg, Germany, since 2016. Before that, she was Full Professor and Vice Chair of the Dept. of Psychiatry, University of Wuerzburg, Germany. Her clinical and teaching focus is on the treatment and prevention of anxiety, stress-related, affective and obsessive-compulsive disorders. Scientifically, Prof. Domschke is a renowned expert in genetics, epigenetics, imaging genetics and pharmacogenetics in the targeted treatment and prevention of anxiety, stress-related, affective and obsessive-compulsive disorders as reflected by to date over 290 publications in international journals and an h-index of 46. She has received funding from the EU, the German Research Foundation (DFG) and the German Ministry of Research and Education (BMBF) and is a full member of ACNP, ECNP, ISPG, SOBP and the German National Academy of Sciences Leopoldina. Prof. Domschke serves on the editorial boards of >10 international journals. Her work has been recognized by e.g. the WFSBP Research Award, the WPA Fellowship Award and the ECNP Fellowship Award.
David Baldwin, United Kingdom (Speaker)
David Baldwin is Professor of Psychiatry and Head of the Mental Health Group in the Clinical and Experimental Sciences Academic Unit of the Faculty of Medicine at the University of Southampton in the UK. He trained in medicine at Charing Cross Hospital Medical School, in psychiatry at St Mary's Hospital Medical School and the Maudsley Hospital, and in medical humanities at Birkbeck College. He is an Honorary Professor in the University of Cape Town in South Africa, and Visiting Professor at Shandong Mental Health Centre in Jinan, China.
David is President-Elect of the British Association for Psychopharmacology, Past President of Depression Alliance, a Medical Patron of Anxiety UK, Editor-in-Chief of Human Psychopharmacology, and author of over 300 full articles in peer-reviewed scientific journals.
He aims to improve clinical outcomes in mood and anxiety disorders: by investigating the role of neurobiological and psychological factors in causing and maintaining illness; through improving trial design when evaluating efficacy and tolerability of treatment interventions; by assessing the effectiveness and acceptability of treatment interventions in wider clinical practice; through identifying more accurately those patient groups at particular risk of poor outcomes. Through Southern Health NHS Foundation Trust, he offers a tertiary referral specialist service to patients with treatment-resistant conditions.
Siegfried Kasper, Austria (Moderator)
Dr. Siegfried Kasper is Professor Emeritus of Psychiatry and former Chairman of the Department of Psychiatry and Psychotherapy at the Medical University of Vienna, Austria. Born in Salzburg, Austria, he was educated at the medical schools of the University of Innsbruck, Austria and the Universities of Freiburg and Heidelberg, Germany. Dr. Kasper gained clinical and research experience in psychiatry at the Central Institute of Mental Health, Mannheim, Germany, the Psychiatric Department of the University of Heidelberg, Germany, the Clinical Psychobiology Branch of the National Institute of Mental Health, Bethesda, Maryland/USA, and the Psychiatric Department of the University of Bonn, Germany; in neurology at the Neurological Department of the University of Heidelberg in Mannheim; and psychotherapeutic and psychoanalytic training at the Ausbildungsinstitut für Psychotherapie und Psychoanalyse in Heidelberg/Mannheim, Germany.